Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alevia-B is a vitamin B-complex supplement developed and marketed by Pascual Laboratories. It contains a combination of three essential B vitamins: thiamine (B1), pyridoxine (B6), and cyanocobalamin (B12). These vitamins serve as vital cofactors in numerous enzymatic reactions throughout the body. Thiamine is essential for carbohydrate metabolism and energy production; pyridoxine is involved in amino acid metabolism, heme biosynthesis, and the synthesis of neurotransmitters like serotonin and dopamine; and cyanocobalamin is critical for DNA synthesis, red blood cell formation, and the maintenance of the myelin sheath surrounding nerves. Alevia-B is primarily indicated for the prevention and treatment of vitamin B deficiencies and for the management of neurological conditions such as neuritis, polyneuritis, and various forms of neuropathy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thiamine + pyridoxine + cyanocobalamin.